Hyper- and hypocoagulability in COVID-19 as assessed by thromboelastometry. Two case reports.

Conclusions: Combinations of biomarkers and thromboelastometry results can be helpful in the future to decide which therapeutic strategy might be most appropriate in individual critically ill COVID-19 patients. This would be an important step to establish precision medicine in this high-risk patient population. PMID: 32773727 [PubMed - as supplied by publisher]
Source: Korean Journal of Anesthesiology - Category: Anesthesiology Tags: Korean J Anesthesiol Source Type: research